Clinical safety monitoring
Monitor participant health with continuous and intermittent vital sign monitoring devices.
Pharma and life sciences
Accelerate innovation for Phase I-IV clinical trials
Continually monitor participant health data with an experienced partner who understands the challenges of new therapy development.
How we support clinical trials
Digital biomarker development
Predict and detect adverse events or indicators of disease progression, enabling early interventions.
Robust data collection and analysis
Capture and monitor participant health data, aiding the analysis of clinical trial endpoints.
Leveraging the power of
technology and human connection
Design participant centric experiences with an adaptable platform.
A broad, flexible technology platform
Our Current Health remote monitoring platform integrates with a wide variety of connected devices to ensure configurability for each clinical trial, while supporting the needs of each participant.
Coupled with end-to-end services and support
Our support serves as an extension of trial site teams to help scale your clinical trial and enhance overall efficiency and safety – from 24/7/365 clinical monitoring and triage of participant vital signs, to clinical operations management and ongoing program success.
Benefits of remote monitoring
Improve participant safety through the early identification of health deterioration, alerting trial sites to potential adverse events and coordinating appropriate interventions.
Deliver more personalized treatment, and support proactive prevention measures for trial participants, while increasing the speed and precision of trial execution through earlier decision-making.
Robust data sets enable the analysis and demonstration of clinical trial endpoints, helping to determine the effectiveness and safety of treatments.
Easier accessibility and reduced barriers for participation help to achieve improved trial enrolment and retention.
“For one patient, after several weeks of continuous monitoring I felt like we had to pry [the device] off of her. She just loved the comfort and the security of knowing that somebody was keeping an eye on her 24/7.”
How we’ve delivered for our partners
Safety and dose optimization
Phase III multi-center study for relapsed or refractory multiple myeloma.
Lack of real-world health data to identify the frequency and severity of CRS, following drug administration.
Continuous and intermittent vital sign monitoring.
- Comprehensive clinical data sets across all study participants
- Detailed insights of therapy impact post administration
- Improved participant safety with a reduction in adverse events
- Increased understanding of dose optimization
- Evaluation of pharmacodynamics and predictive biomarkers
- Multi country open label study
- Up to 80 participants
- ~ 30 trial sites
Safety, efficacy, and pharmacokinetic evaluation
Phase IIA multicenter study for severe postpartum depression.
Evaluate safety, tolerability, pharmacokinetics, and descriptive efficacy following drug administration in adults with severe postpartum depression.
Continuous vital sign and fall detection monitoring with ePROs.
- Understand safety and tolerability following administration
- Characterize the pharmacokinetic profile
- Determine if depressive symptoms are reduced
- Determine if treatment improves social functioning
- US study
- ~ 24 participants
- ~ 15 trial sites
- Caring Center service providing near real time monitoring and urgent response 24/7/365 via Lively
Feasibility of outpatient treatment plan
Dose escalation study of CAR-T dose administration.
Evaluate the feasibility of an outpatient treatment plan for participants in a dose escalation study.
Continuous and intermittent vital sign monitoring.
- Demonstrate the feasibility of outpatient treatment model
- Early detection of CRS onset
- Multi-country study
- ~ 10 participants
- ~ 5 trial sites
Certified platform for global delivery
-
FDA Class II 510(k) clearance
-
EU Class IIa CE-marked
-
Australia & New Zealand TGA certification
-
US, EU, ASPAC and Africa Global platform delivery
-
30,000+ patients monitored
Recommended resources
Maximizing the Impact of Acute Care at Home: Three Health Systems Share their Success
Acute care at home is transforming healthcare. By enabling health systems to provide hosp…
Hospital is Not the Home: 8 Lessons Learned from Implementing RPM for Acute and Transitional Care at Home
While we’ve grown accustomed to collecting and analyzing data in a hospital setting, mo…
Research: Maximizing the Indirect Benefits of Hospital at Home
The healthcare landscape is rapidly transforming, with hospital-at-home programs leading …